115 related articles for article (PubMed ID: 38457838)
21. Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.
Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
Recent Results Cancer Res; 2013; 194():353-71. PubMed ID: 22918768
[TBL] [Abstract][Full Text] [Related]
22. Superiority of
Jha A; Ling A; Millo C; Gupta G; Viana B; Lin FI; Herscovitch P; Adams KT; Taïeb D; Metwalli AR; Linehan WM; Brofferio A; Stratakis CA; Kebebew E; Lodish M; Civelek AC; Pacak K
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):787-797. PubMed ID: 29204718
[TBL] [Abstract][Full Text] [Related]
23. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Positron Emission Tomography Quantification Using Magnetic Resonance- and Computed Tomography-Based Attenuation Correction in Physiological Tissues and Lesions: A Whole-Body Positron Emission Tomography/Magnetic Resonance Study in 66 Patients.
Seith F; Gatidis S; Schmidt H; Bezrukov I; la Fougère C; Nikolaou K; Pfannenberg C; Schwenzer N
Invest Radiol; 2016 Jan; 51(1):66-71. PubMed ID: 26348596
[TBL] [Abstract][Full Text] [Related]
25. Whole-Body Integrated [
Guberina N; Hetkamp P; Ruebben H; Fendler W; Grueneisen J; Suntharalingam S; Kirchner J; Puellen L; Harke N; Radtke JP; Umutlu L; Hadaschik BA; Herrmann K; Forsting M; Wetter A
Mol Imaging Biol; 2020 Jun; 22(3):788-796. PubMed ID: 31482413
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of 3D volumetric image registration based on CT, MR and PET/CT phantom experiments.
Li G; Xie H; Ning H; Citrin D; Capala J; Maass-Moreno R; Guion P; Arora B; Coleman N; Camphausen K; Miller RW
J Appl Clin Med Phys; 2008 Jul; 9(4):17-36. PubMed ID: 19020479
[TBL] [Abstract][Full Text] [Related]
27. The utility of
Shell J; Tirosh A; Millo C; Sadowski SM; Assadipour Y; Green P; Patel D; Nilubol N; Kebebew E
Eur J Radiol; 2019 Mar; 112():130-135. PubMed ID: 30777201
[TBL] [Abstract][Full Text] [Related]
28. The added value of PET/Ce-CT/DW-MRI fusion in assessment of hepatic focal lesions: PET/Ce-CT/DW-MRI fusion in hepatic focal lesion.
Salem S; Houseni M; Zidan L; Kandil A
Nucl Med Biol; 2015 Jul; 42(7):637-42. PubMed ID: 25907467
[TBL] [Abstract][Full Text] [Related]
29. Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT.
Varoquaux A; Rager O; Poncet A; Delattre BM; Ratib O; Becker CD; Dulguerov P; Dulguerov N; Zaidi H; Becker M
Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):462-75. PubMed ID: 24108458
[TBL] [Abstract][Full Text] [Related]
30. Clinical value of ⁶⁸Ga-DOTATATE-PET/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET).
Albanus DR; Apitzsch J; Erdem Z; Erdem O; Verburg FA; Behrendt FF; Mottaghy FM; Heinzel A
Eur J Radiol; 2015 Oct; 84(10):1866-72. PubMed ID: 26152870
[TBL] [Abstract][Full Text] [Related]
31. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
[TBL] [Abstract][Full Text] [Related]
32. Software-based PET-MR image coregistration: combined PET-MRI for the rest of us!
Robertson MS; Liu X; Plishker W; Zaki GF; Vyas PK; Safdar NM; Shekhar R
Pediatr Radiol; 2016 Oct; 46(11):1552-61. PubMed ID: 27380195
[TBL] [Abstract][Full Text] [Related]
33. Phantom validation of coregistration of PET and CT for image-guided radiotherapy.
Lavely WC; Scarfone C; Cevikalp H; Li R; Byrne DW; Cmelak AJ; Dawant B; Price RR; Hallahan DE; Fitzpatrick JM
Med Phys; 2004 May; 31(5):1083-92. PubMed ID: 15191296
[TBL] [Abstract][Full Text] [Related]
34. Automated detection, delineation and quantification of whole-body bone metastasis using FDG-PET/CT images.
Nigam R; Field M; Harris G; Barton M; Carolan M; Metcalfe P; Holloway L
Phys Eng Sci Med; 2023 Jun; 46(2):851-863. PubMed ID: 37126152
[TBL] [Abstract][Full Text] [Related]
35. An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose
Loft M; Ladefoged CN; Johnbeck CB; Carlsen EA; Oturai P; Langer SW; Knigge U; Andersen FL; Kjaer A
J Nucl Med; 2023 Jun; 64(6):951-959. PubMed ID: 37169532
[TBL] [Abstract][Full Text] [Related]
36. Performance of an automated registration-based method for longitudinal lesion matching and comparison to inter-reader variability.
Huff DT; Santoro-Fernandes V; Chen S; Chen M; Kashuk C; Weisman AJ; Jeraj R; Perk TG
Phys Med Biol; 2023 Aug; 68(17):. PubMed ID: 37567220
[No Abstract] [Full Text] [Related]
37. Application of a Flexible PET Scanner Combined with 3 T MRI Using Non-local Means Reconstruction: Qualitative and Quantitative Comparison with Whole-Body PET/CT.
Watanabe M; Kawai-Miyake K; Fushimi Y; Ishimori T; Nakajima A; Yoshimura M; Kikuchi M; Ohno K; Nakamoto Y
Mol Imaging Biol; 2022 Feb; 24(1):167-176. PubMed ID: 34642900
[TBL] [Abstract][Full Text] [Related]
38. Comparison of ⁶⁸Ga-DOTATATE and ⁶⁸Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours.
Kabasakal L; Demirci E; Ocak M; Decristoforo C; Araman A; Ozsoy Y; Uslu I; Kanmaz B
Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1271-7. PubMed ID: 22526963
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
[TBL] [Abstract][Full Text] [Related]
40. 68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy.
Gabriel M; Oberauer A; Dobrozemsky G; Decristoforo C; Putzer D; Kendler D; Uprimny C; Kovacs P; Bale R; Virgolini IJ
J Nucl Med; 2009 Sep; 50(9):1427-34. PubMed ID: 19690033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
